X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (8) 8
life sciences (8) 8
male (6) 6
dermatology (5) 5
female (5) 5
melanoma (5) 5
middle aged (5) 5
survival (5) 5
aged (4) 4
aged, 80 and over (4) 4
cancer (4) 4
malignant-melanoma (4) 4
oncology (4) 4
skin neoplasms - pathology (4) 4
[sdv.mhep.derm]life sciences [q-bio]/human health and pathology/dermatology (3) 3
adult (3) 3
animals (3) 3
cutaneous melanoma (3) 3
human health and pathology (3) 3
melanoma - genetics (3) 3
melanoma - pathology (3) 3
mice (3) 3
mice, inbred c57bl (3) 3
mutation (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
[sdv]life sciences [q-bio] (2) 2
abridged index medicus (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - therapeutic use (2) 2
base sequence (2) 2
cyclin-dependent kinase inhibitor p16 - genetics (2) 2
gene-expression (2) 2
genes (2) 2
genetic predisposition to disease (2) 2
germ-line mutation (2) 2
identification (2) 2
ipilimumab (2) 2
localization (2) 2
lymphatic metastasis (2) 2
metastases (2) 2
molecular sequence data (2) 2
neoplasm staging (2) 2
p16 (2) 2
pancreatic-cancer (2) 2
pregnancy (2) 2
prone families (2) 2
retrospective studies (2) 2
reverse transcriptase polymerase chain reaction (2) 2
risk (2) 2
skin (2) 2
skin neoplasms - mortality (2) 2
surgery (2) 2
treatment outcome (2) 2
young adult (2) 2
[sdv.can]life sciences [q-bio]/cancer (1) 1
[sdv.gen.gh]life sciences [q-bio]/genetics/human genetics (1) 1
[sdv.mhep]life sciences [q-bio]/human health and pathology (1) 1
adolescent (1) 1
adverse events (1) 1
affinity (1) 1
agent cetuximab (1) 1
amelanotic melanoma (1) 1
amino acid sequence (1) 1
analysis (1) 1
angiogenesis (1) 1
annexin a1 (1) 1
annexin a1 - chemistry (1) 1
annexin a1 - metabolism (1) 1
annexins (1) 1
anti-ctla-4 (1) 1
anti-tnf alpha (1) 1
antibodies, monoclonal, humanized (1) 1
antibody cetuximab (1) 1
autoimmune disease (1) 1
benzamide (1) 1
benzamides - pharmacokinetics (1) 1
biodistribution (1) 1
biomedicine (1) 1
biomedicine general (1) 1
biopsy (1) 1
blood-brain barrier - physiology (1) 1
brain metastases (1) 1
brain neoplasms - secondary (1) 1
brain neoplasms - therapy (1) 1
breast-cancer (1) 1
breast-cancer patients (1) 1
cancer and oncology (1) 1
cancer cells (1) 1
cancer och onkologi (1) 1
cancer research (1) 1
carcinoma (1) 1
carcinoma, merkel cell - immunology (1) 1
carcinoma, merkel cell - mortality (1) 1
carcinoma, merkel cell - pathology (1) 1
carcinoma, merkel cell - therapy (1) 1
carcinoma, renal cell (1) 1
carcinoma, renal cell - genetics (1) 1
carcinoma, squamous cell - drug therapy (1) 1
carcinoma, squamous cell - secondary (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
by Bertolotto, Corine and Lesueur, Fabienne and Giuliano, Sandy and Strub, Thomas and De Lichy, Mahaut and Bille, Karine and Dessen, Philippe and D'Hayer, Benoit and Mohamdi, Hamida and Remenieras, Audrey and Maubec, Eve and De La Fouchardière, Arnaud and Molinié, Vincent and Vabres, Pierre and Dalle, Stéphane and Poulalhon, Nicolas and Martin-Denavit, Tanguy and Thomas, Luc and Andry-Benzaquen, Pascale and Dupin, Nicolas and Boitier, Fraņoise and Rossi, Annick and Perrot, Jean-Luc and Labeille, Bruno and Robert, Caroline and Escudier, Bernard and Caron, Olivier and Brugières, Laurence and Saule, Simon and Gardie, Betty and Gad, Sophie and Richard, Stéphane and Couturier, Jérôme and Teh, Bin Tean and Ghiorzo, Paola and Pastorino, Lorenza and Puig, Susana and Badenas, Celia and Olsson, Hakan and Ingvar, Christian and Rouleau, Etienne and Lidereau, Rosette and Bahadoran, Philippe and Vielh, Philippe and Corda, Eve and Blanché, Hélène and Zelenika, Diana and Galan, Pilar and Aubin, Fraņois and Bachollet, Bertrand and Becuwe, Céline and Berthet, Pascaline and Jean Bignon, Yves and Bonadona, Valérie and Bonafe, Jean-Louis and Bonnet-Dupeyron, Marie-Noëlle and Cambazard, Fréderic and Chevrant-Breton, Jacqueline and Coupier, Isabelle and Dalac, Sophie and Demange, Liliane and D'Incan, Michel and Dugast, Catherine and Faivre, Laurence and Vincent-Fétita, Lynda and Gauthier-Villars, Marion and Gilbert, Brigitte and Grange, Florent and Grob, Jean-Jacques and Humbert, Philippe and Janin, Nicolas and Joly, Pascal and Kerob, Delphine and Lasset, Christine and Leroux, Dominique and Levang, Julien and Limacher, Jean-Marc and Livideanu, Cristina and Longy, Michel and Lortholary, Alain and Stoppa-Lyonnet, Dominique and Mansard, Sandrine and Mansuy, Ludovic and Marrou, Karine and Matéus, Christine and Maugard, Christine and Meyer, Nicolas and Nogues, Catherine and Souteyrand, Pierre and Venat-Bouvet, Laurence and Zattara, Hélène and Chaudru, Valérie and Lenoir, Gilbert M and Lathrop, Mark and Davidson, Irwin and Avril, Marie-Fraņoise and Demenais, Florence and Ballotti, Robert and Bressac-De Paillerets, Brigitte and French Familial Melanoma Study Grp and French Familial Melanoma Study Group and The French Familial Melanoma Study Group and Surgery (Lund) and Lund University and Cancer Epidemiology and Cancerepidemiologi and EpiHealth: Epidemiology for Health and Kirurgi, Lund and BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation and Lunds universitet
Nature, ISSN 0028-0836, 12/2011, Volume 480, Issue 7375, pp. 94 - 98
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2012, Volume 67, Issue 6, pp. 1257 - 1264.e2
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 9551 - 9551
Journal Article
JOURNAL OF IMMUNOTHERAPY, ISSN 1524-9557, 06/2019, Volume 42, Issue 5, pp. 175 - 179
Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and... 
SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | colitis | MONOTHERAPY | COMBINED NIVOLUMAB | melanoma | anti-TNF alpha | IMMUNOLOGY | CANCER | CHEMOTHERAPY | PEMBROLIZUMAB | TOXICITIES | ANTI-CTLA-4 | ONCOLOGY | ADVERSE EVENTS | IPILIMUMAB
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2019, Volume 71, Issue 12, pp. 2100 - 2111
Objective Immune checkpoint inhibitors (ICIs) for cancer therapy frequently induce immune‐related adverse effects (IRAEs). Therefore, most patients with... 
Life Sciences
Journal Article
Journal of immunotherapy (Hagerstown, Md. : 1997), 05/2019
Immune checkpoint inhibitors (ICI) significantly improve overall survival (OS) in patients with advanced melanoma, but immune-related colitis may occur and... 
Journal Article
Acta Dermato-Venereologica, ISSN 0001-5555, 09/2015, Volume 95, Issue 7, pp. 835 - 840
Journal Article